CA2585779C - In-situ forming implant for animals - Google Patents

In-situ forming implant for animals Download PDF

Info

Publication number
CA2585779C
CA2585779C CA2585779A CA2585779A CA2585779C CA 2585779 C CA2585779 C CA 2585779C CA 2585779 A CA2585779 A CA 2585779A CA 2585779 A CA2585779 A CA 2585779A CA 2585779 C CA2585779 C CA 2585779C
Authority
CA
Canada
Prior art keywords
composition
composition according
release
polymer
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2585779A
Other languages
English (en)
French (fr)
Other versions
CA2585779A1 (en
Inventor
Caroline Sautter
Ute Isele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elanco Tiergesundheit AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of CA2585779A1 publication Critical patent/CA2585779A1/en
Application granted granted Critical
Publication of CA2585779C publication Critical patent/CA2585779C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
CA2585779A 2004-12-14 2005-12-13 In-situ forming implant for animals Expired - Fee Related CA2585779C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04029498 2004-12-14
EP04029498.5 2004-12-14
PCT/EP2005/013377 WO2006063794A1 (en) 2004-12-14 2005-12-13 In-situ forming implant for animals

Publications (2)

Publication Number Publication Date
CA2585779A1 CA2585779A1 (en) 2006-06-22
CA2585779C true CA2585779C (en) 2014-01-28

Family

ID=34927750

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2585779A Expired - Fee Related CA2585779C (en) 2004-12-14 2005-12-13 In-situ forming implant for animals

Country Status (16)

Country Link
JP (1) JP5372378B2 (de)
KR (1) KR101304160B1 (de)
CN (1) CN101056617B (de)
AR (1) AR052155A1 (de)
AT (1) ATE389386T1 (de)
AU (1) AU2005315823B2 (de)
BR (1) BRPI0519022A2 (de)
CA (1) CA2585779C (de)
DE (1) DE602005005522T2 (de)
ES (1) ES2301084T3 (de)
MX (1) MX2007007099A (de)
NZ (1) NZ554904A (de)
RU (1) RU2394558C2 (de)
TW (1) TWI369218B (de)
WO (1) WO2006063794A1 (de)
ZA (1) ZA200703506B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
CN101801415B (zh) 2007-05-25 2015-09-23 Rb医药品有限公司 利培酮化合物的持续递送制剂
CN101159064B (zh) 2007-11-29 2010-09-01 腾讯科技（深圳）有限公司 画像生成系统以及按照图像生成画像的方法
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP6543431B2 (ja) * 2013-10-10 2019-07-10 ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 眼内薬物送達デバイスおよび付随する方法
WO2018189314A1 (en) * 2017-04-13 2018-10-18 Ceva Sante Animale Composition for treating worms infestations
CN112336682B (zh) * 2020-09-28 2022-07-08 浙江大学 具有缓控释药物作用的可注射复合载体与组合物及制备方法
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
AU739469B2 (en) * 1996-12-20 2001-10-11 Alza Corporation Gel composition and methods
ME00867B (me) * 1998-03-19 2008-08-07 Merck Sharp & Dohme Tečne polimerne smeše za kontrolisano oslobađanje bioaktivnih supstanci
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
JP4317606B2 (ja) * 1998-09-18 2009-08-19 サンスター株式会社 固体粒子形成用組成物
BR0315304A (pt) * 2002-11-06 2005-08-16 Alza Corp Formulações com depósito para liberação controlada
CA2518791A1 (en) * 2003-03-11 2004-09-23 Qlt Usa Inc. Formulations for cell-schedule dependent anticancer agents

Also Published As

Publication number Publication date
ZA200703506B (en) 2008-09-25
RU2394558C2 (ru) 2010-07-20
AR052155A1 (es) 2007-03-07
KR101304160B1 (ko) 2013-09-04
JP2008523131A (ja) 2008-07-03
MX2007007099A (es) 2007-06-22
DE602005005522D1 (de) 2008-04-30
CN101056617B (zh) 2012-07-11
CA2585779A1 (en) 2006-06-22
TWI369218B (en) 2012-08-01
JP5372378B2 (ja) 2013-12-18
AU2005315823B2 (en) 2009-06-04
DE602005005522T2 (de) 2009-04-16
AU2005315823A1 (en) 2006-06-22
NZ554904A (en) 2009-11-27
KR20070092964A (ko) 2007-09-14
RU2007126759A (ru) 2009-01-27
BRPI0519022A2 (pt) 2008-12-23
CN101056617A (zh) 2007-10-17
TW200635616A (en) 2006-10-16
WO2006063794A1 (en) 2006-06-22
ATE389386T1 (de) 2008-04-15
ES2301084T3 (es) 2008-06-16

Similar Documents

Publication Publication Date Title
CA2585779C (en) In-situ forming implant for animals
ES2359973T3 (es) Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
EP1484033B1 (de) Flüssige Polymerlosung zur Kontrollierten freisetzung von bioaktiven substanzen
KR101865689B1 (ko) 부프레노르핀을 포함하는 주입가능한 유동성 조성물
KR102189442B1 (ko) 소수성 조성물용 생분해성 약물 전달
EP2244752B1 (de) Niederviskos-flüssigpolymer-zuführungssystem
US8017144B2 (en) Controlled release polymeric compositions of bone growth promoting compounds
JP4599498B2 (ja) 非ポリマー持続性解離供給システム
ES2272024T3 (es) Emulsiones para sistemas de administracion in situ.
JPH05286850A (ja) 放出を制御されたインプラントに使用する液状混合物、インプラントに好適なポリマーシステム及びそのポリマーシステムを用いた治療方法
WO1996021427A1 (en) Liquid polymer delivery system
HU228386B1 (hu) Javított hatékonyságú leuprolid polimeres bejuttatására szolgáló készítmények
KR20000069264A (ko) 고체 또는 반-고체의 국부 투입 장치와 비경구적 투약을 위한서방성 제재와 그 제재의 제조 방법
EP1827377B1 (de) In-situ-erzeugung eines implantats für tiere
JP2005538052A (ja) 注射製剤
PT1484033E (pt) Composições poliméricas líquidas para libertação controlada de substâncias bioactivas

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20161213